Microalgae are microorganisms that have different morphological, physiological, and genetic traits that confer the ability to produce different biologically active metabolites. Microalgal biotechnology has become a subject of study for various fields, due to the varied bioproducts that can be obtained from these microorganisms. When microalgal cultivation processes are better understood, microalgae can become an environmentally friendly and economically viable source of compounds of interest, because production can be optimized in a controlled culture. The bioactive compounds derived from microalgae have anti-inflammatory, antimicrobial, and antioxidant activities, among others. Furthermore, these microorganisms have the ability to promote health and reduce the risk of the development of degenerative diseases. In this context, the aim of this review is to discuss bioactive metabolites produced by microalgae for possible applications in the life sciences.

No abstract

Spirulina is produced from pure cultures of the photosynthetic prokaryotic cyanobacteria Arthrospira. For many years research centers throughout the world have studied its application in various scientific fields, especially in foods and medicine. The biomass produced from Spirulina cultivation contains a variety of biocompounds, including biopeptides, biopolymers, carbohydrates, essential fatty acids, minerals, oligoelements, and sterols. Some of these compounds are bioactive and have anti-inflammatory, antibacterial, antioxidant, and antifungal properties. These compounds can be used in tissue engineering, the interdisciplinary field that combines techniques from cell science, engineering, and materials science and which has grown in importance over the past few decades. Spirulina biomass can be used to produce polyhydroxyalkanoates (PHAs), biopolymers that can substitute synthetic polymers in the construction of engineered extracellular matrices (scaffolds) for use in tissue cultures or bioactive molecule construction. This review describes the development of nanostructured scaffolds based on biopolymers extracted from microalgae and biomass from Spirulina production. These scaffolds have the potential to encourage cell growth while reducing the risk of organ or tissue rejection.

Carbohydrates or polysaccharides are the main products derived from photosynthesis and carbon fixation in the Calvin cycle. Compared to other sources, polysaccharides derived from microalgae are safe, biocompatible, biodegradable, stable, and versatile. These polymeric macromolecules present complex biochemical structures according to each microalgal species. In addition, they exhibit emulsifying properties and biological characteristics that include antioxidant, anti-inflammatory, antitumor, and antimicrobial activities. Some microalgal species have a naturally high concentration of carbohydrates. Other species can adapt their metabolism to produce more sugars from changes in temperature and light, carbon source, macro and micronutrient limitations (mainly nitrogen), and saline stress. In addition to growing in adverse conditions, microalgae can use industrial effluents as an alternative source of nutrients. Microalgal polysaccharides are predominantly composed of pentose and hexose monosaccharide subunits with many glycosidic bonds. Microalgae polysaccharides can be structural constituents of the cell wall, energy stores, or protective polysaccharides and cell interaction. The industrial use of microalgae polysaccharides is on the rise. These microorganisms present rheological and biological properties, making them a promising candidate for application in the food industry and agriculture. Thus, microalgae polysaccharides are promising sustainable alternatives for potential applications in several sectors, and the choice of producing microalgal species depends on the required functional activity. In this context, this review article aims to provide an overview of microalgae technology for polysaccharide production, emphasizing its potential in the food, animal feed, and agriculture sector.

No abstract